1. Home
  2. DGX vs BEKE Comparison

DGX vs BEKE Comparison

Compare DGX & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
  • BEKE
  • Stock Information
  • Founded
  • DGX 1967
  • BEKE 2001
  • Country
  • DGX United States
  • BEKE China
  • Employees
  • DGX N/A
  • BEKE N/A
  • Industry
  • DGX Medical Specialities
  • BEKE Real Estate
  • Sector
  • DGX Health Care
  • BEKE Finance
  • Exchange
  • DGX Nasdaq
  • BEKE Nasdaq
  • Market Cap
  • DGX 20.5B
  • BEKE 22.4B
  • IPO Year
  • DGX 1996
  • BEKE 2020
  • Fundamental
  • Price
  • DGX $180.17
  • BEKE $20.00
  • Analyst Decision
  • DGX Buy
  • BEKE Strong Buy
  • Analyst Count
  • DGX 15
  • BEKE 6
  • Target Price
  • DGX $185.40
  • BEKE $24.97
  • AVG Volume (30 Days)
  • DGX 692.9K
  • BEKE 6.2M
  • Earning Date
  • DGX 10-21-2025
  • BEKE 08-26-2025
  • Dividend Yield
  • DGX 1.77%
  • BEKE 1.81%
  • EPS Growth
  • DGX 12.66
  • BEKE N/A
  • EPS
  • DGX 8.35
  • BEKE 0.46
  • Revenue
  • DGX $10,522,000,000.00
  • BEKE $14,384,647,393.00
  • Revenue This Year
  • DGX $11.12
  • BEKE $16.76
  • Revenue Next Year
  • DGX $3.41
  • BEKE $12.40
  • P/E Ratio
  • DGX $21.63
  • BEKE $42.75
  • Revenue Growth
  • DGX 12.58
  • BEKE 32.52
  • 52 Week Low
  • DGX $146.17
  • BEKE $13.30
  • 52 Week High
  • DGX $185.62
  • BEKE $26.05
  • Technical
  • Relative Strength Index (RSI)
  • DGX 51.80
  • BEKE 64.69
  • Support Level
  • DGX N/A
  • BEKE $19.57
  • Resistance Level
  • DGX $185.05
  • BEKE $20.33
  • Average True Range (ATR)
  • DGX 2.38
  • BEKE 0.42
  • MACD
  • DGX -6.91
  • BEKE 0.17
  • Stochastic Oscillator
  • DGX 97.36
  • BEKE 88.39

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.

Share on Social Networks: